Skip to main content
. 2015 Sep 23;16(9):23094–23110. doi: 10.3390/ijms160923094

Table 1.

Recent studies using deep mutational scanning.

Mutation Generation Method 1 Variant Library Sequencing Method 2 Target Protein 3 Reference
ORM Phage display Solexa/PE PSD95pdz3 [10]
ORM Bacterial two-hybrid Illumina/PE hYAP65 [22]
ORM Yeast two-hybrid Illumina/SE BRCA1 [27]
PRM Plasmid Illumina/SE EcFbFP [21]
SM Yeast display Illumina/PE HB80.3 [24]
ORM Plasmid Illumina/PE APH(3′)II [28]
SM Plasmid Illumina/PE Bgl3 [23]
SM Plasmid 454 CcdB [26]
ORM Plasmid Illumina/PE Pab1 [29]
ORM Mammalian display vectors 454 IgG [30]
ORM Ribosome display 454 CDR loops of Fab [47]
ORM Phage display Illumina/PE hYAP65 [48]

1 ORM: Oligonucleotide-directed random mutagenesis; PRM: PCR-based random mutagenesis; SM: Saturated mutagenesis; 2 PE: paired-end; SE: single-end; 3 PDZ domain: post synaptic density protein; hYAP65: human Yes-associated protein 65; BRCA1: breast cancer 1 (early onset); EcFbFP: Escherichia coli flavin mononucleotide binding fluorescent protein; HB80.3: HB80.3 (designed high affinity binding protein); APH(3′)II: Tn5 transposon derived aminoglycoside-3′-phosphotransferase-II; Bgl3: β-glucosidase; CcdB: bacterial toxin protein CcdB; Pab1: poly(A)-binding protein; IgG: immunoglobulin G; CDR: complementary determining region; Fab: fragment antigen-binding region.